Clinical Department, Institute of Haematology and Blood Transfusion, Prague, Czech Republic.
Division of Haematology and Immunology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Int J Lab Hematol. 2022 Oct;44(5):868-874. doi: 10.1111/ijlh.13877. Epub 2022 May 25.
The reliable diagnosis of paroxysmal nocturnal haemoglobinuria (PNH) by flow cytometry is based on mandatory analysis of the erythroid, neutrophilic and monocytic lineages. In this study, we have evaluated the performance characteristics of a recently published immature red blood cell (iRBC) assay as a potential screening test for PNH by flow cytometry.
Intra- and inter-assay imprecision were determined in five replicates of small, medium and large PNH iRBC clones. Analytical and functional sensitivity was assessed by performing spiking tests for five replicates. Thirty healthy donors and 441 PNH patients were tested for evaluation of clinical specificity, sensitivity, positive and negative predictive values.
Coefficients of variation (CV) for intra-/inter-assay imprecision analyses were 1.31/1.50, 3.19/2.61 and 3.99/1.58 for the big, medium and small clone sizes, respectively. Absolute values (100%) were found for both clinical specificity and sensitivity as well as for both positive and negative predictive values. The CV from 5 replicate results for 10 clustered events was 15.7%. The coefficient of determination (r ), Pearson's correlation coefficient (r) and Bland-Altman mean bias were 0.9436/0.9234/1.7 for PNH iRBC compared to PNH neutrophils and 0.9553/0.9387/2.1 for PNH iRBCs compared to PNH monocytes.
Our results confirm very good performance characteristics, high analytical and functional sensitivity, absolute clinical specificity and sensitivity as well as favourable correlation between PNH iRBCs and both PNH neutrophils and monocytes, suggesting that this cost-effective 3-colour iRBC assay can be used as a reliable screening test for evaluation of small, medium and large PNH clones by flow cytometry.
通过流式细胞术可靠诊断阵发性夜间血红蛋白尿症(PNH)的基础是对红系、粒系和单核系的强制性分析。在本研究中,我们评估了一种最近发表的未成熟红细胞(iRBC)检测方法作为流式细胞术检测 PNH 的潜在筛选试验的性能特征。
在小、中、大 PNH iRBC 克隆的 5 个重复样本中,分别测定批内和批间精密度。通过 5 个重复的加标试验评估分析和功能灵敏度。对 30 名健康供体和 441 名 PNH 患者进行检测,以评估临床特异性、敏感性、阳性和阴性预测值。
批内/批间精密度分析的变异系数(CV)分别为大、中、小克隆大小的 1.31/1.50、3.19/2.61 和 3.99/1.58。临床特异性和敏感性以及阳性和阴性预测值的绝对值(100%)均为 100%。10 个簇事件的 5 个重复结果的 CV 为 15.7%。与 PNH 中性粒细胞相比,PNH iRBC 的决定系数(r )、皮尔逊相关系数(r)和 Bland-Altman 平均偏差分别为 0.9436/0.9234/1.7,与 PNH 单核细胞相比,分别为 0.9553/0.9387/2.1。
我们的结果证实了非常好的性能特征、高分析和功能灵敏度、绝对临床特异性和敏感性,以及 PNH iRBC 与 PNH 中性粒细胞和单核细胞之间的良好相关性,提示这种具有成本效益的 3 色 iRBC 检测可以作为一种可靠的筛选试验,用于通过流式细胞术评估小、中、大 PNH 克隆。